4basebio Plc Director/PDMR Shareholding
July 13 2022 - 2:00AM
UK Regulatory
TIDM4BB
13 July 2022
4basebio plc
(the "Company")
Director's Dealing
4basebio PLC (AIM: 4BB), the specialist life sciences group focused on
exploiting intellectual property in the field of cell and gene therapies and
DNA vaccines, announces that it was notified on 12 July 2022 that Dr Heikki
Lanckriet, chief executive officer, on the same day transferred 29,000 ordinary
shares at a price of 415 pence per share from his personal holding into his
SIPP (the "Transfer").
Following the Transfer, there is no change to Dr Heikki Lanckriet's beneficial
holding, and his interest in the Company remains at 1,252,453 Ordinary Shares,
representing approximately 10.17% of the Company's issued share capital.
This announcement contains inside information for the purposes of Article 7 of
EU Regulation 596/2014.
For further enquiries, please contact:
4basebio plc +44 (0)12 2396 7943
Heikki Lanckriet, CEO
Cairn Financial Advisers LLP (Nominated +44 (0)20 7213 0880
Adviser)
Jo Turner / Sandy Jamieson
finnCap Ltd (Broker) +44 (0)20 7220 0500
Geoff Nash/Richard Chambers/Charlotte
Sutcliffe
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No.
596/2014
1 Details of the person discharging managerial responsibilities/person closely
associated
a. Name Dr Heikki Lanckriet
2 Reason for
notification
a. Position/Status Chief Executive Officer
b. Initial notification Initial Notification
/
Amendment
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a. Name 4basebio plc
b. LEI 213800E2DX9EAIUNCB30
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a. Description of the Ordinary shares
financial
instrument, type of
instrument ISIN: GB00BMCLYF79
Identification Code
b. Nature of the Transfer from nominee account to SIPP
transaction
c. Price(s) and volume Price(s) per Volume(s)
(s) share (p)
415p 29,000
d. Aggregated * 29,000
information * 415 pence per share
e. Date of the 12/07/2022
transaction
f. Place of the London Stock Exchange, AIM
transaction
END
(END) Dow Jones Newswires
July 13, 2022 02:00 ET (06:00 GMT)
4basebio (LSE:4BB)
Historical Stock Chart
From Apr 2024 to May 2024
4basebio (LSE:4BB)
Historical Stock Chart
From May 2023 to May 2024